193 related articles for article (PubMed ID: 32689903)
1. Mice Hypomorphic for
Ziros PG; Renaud CO; Chartoumpekis DV; Bongiovanni M; Habeos IG; Liao XH; Refetoff S; Kopp PA; Brix K; Sykiotis GP
Thyroid; 2021 Jan; 31(1):23-35. PubMed ID: 32689903
[No Abstract] [Full Text] [Related]
2. NFE2-Related Transcription Factor 2 Coordinates Antioxidant Defense with Thyroglobulin Production and Iodination in the Thyroid Gland.
Ziros PG; Habeos IG; Chartoumpekis DV; Ntalampyra E; Somm E; Renaud CO; Bongiovanni M; Trougakos IP; Yamamoto M; Kensler TW; Santisteban P; Carrasco N; Ris-Stalpers C; Amendola E; Liao XH; Rossich L; Thomasz L; Juvenal GJ; Refetoff S; Sykiotis GP
Thyroid; 2018 Jun; 28(6):780-798. PubMed ID: 29742982
[TBL] [Abstract][Full Text] [Related]
3. Rare and common genetic variations in the Keap1/Nrf2 antioxidant response pathway impact thyroglobulin gene expression and circulating levels, respectively.
Matana A; Ziros PG; Chartoumpekis DV; Renaud CO; Polašek O; Hayward C; Zemunik T; Sykiotis GP
Biochem Pharmacol; 2020 Mar; 173():113605. PubMed ID: 31421134
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic profiling of the response to excess iodide in Keap1 hypomorphic mice reveals new gene-environment interactions in thyroid homeostasis.
Ziros PG; Chartoumpekis DV; Georgakopoulos-Soares I; Psarias G; Sykiotis GP
Redox Biol; 2024 Feb; 69():102978. PubMed ID: 38048653
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
[TBL] [Abstract][Full Text] [Related]
6. Identification of a KEAP1 germline mutation in a family with multinodular goitre.
Teshiba R; Tajiri T; Sumitomo K; Masumoto K; Taguchi T; Yamamoto K
PLoS One; 2013; 8(5):e65141. PubMed ID: 23724128
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of Keap1/Nrf2 signaling in the thyroid gland and perspectives for bench-to-bedside translation.
Chartoumpekis DV; Ziros PG; Habeos IG; Sykiotis GP
Free Radic Biol Med; 2022 Sep; 190():276-283. PubMed ID: 35988853
[TBL] [Abstract][Full Text] [Related]
8. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic mutations in KEAP1 disturbing inhibitory Nrf2-Keap1 interaction: Activation of antioxidative pathway in papillary thyroid carcinoma.
Danilovic DLS; de Mello ES; Frazzato EST; Wakamatsu A; de Lima Jorge AA; Hoff AO; Marui S
Head Neck; 2018 Jun; 40(6):1271-1278. PubMed ID: 29469959
[TBL] [Abstract][Full Text] [Related]
11. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
12. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
[TBL] [Abstract][Full Text] [Related]
14. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
15.
Stuchi LP; Castanhole-Nunes MMU; Maniezzo-Stuchi N; Biselli-Chicote PM; Henrique T; Padovani Neto JA; de-Santi Neto D; Girol AP; Pavarino EC; Goloni-Bertollo EM
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32824922
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter.
Berghout A; Wiersinga WM; Smits NJ; Touber JL
Am J Med; 1990 Nov; 89(5):602-8. PubMed ID: 2239979
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
18. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.
Vermiglio F; Benvenga S; Melluso R; Catalfamo S; Princi P; Battiato S; Consolo F; Trimarchi F
J Endocrinol Invest; 1986 Oct; 9(5):389-96. PubMed ID: 3098822
[TBL] [Abstract][Full Text] [Related]
19. Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2).
Tian W; Rojo de la Vega M; Schmidlin CJ; Ooi A; Zhang DD
J Biol Chem; 2018 Feb; 293(6):2029-2040. PubMed ID: 29255090
[TBL] [Abstract][Full Text] [Related]
20. NRF2 pathway activation by KEAP1 inhibition attenuates the manifestation of aging phenotypes in salivary glands.
Wati SM; Matsumaru D; Motohashi H
Redox Biol; 2020 Sep; 36():101603. PubMed ID: 32590331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
